Year None202320222021202020192018201720162015201420132012 12.06.2019 Iveric Bio Announces Pricing of Public Offering of Common Stock 12.05.2019 Iveric Bio Announces Proposed Offering of Common Stock 11.26.2019 Iveric Bio to Present at Evercore ISI 2nd Annual HealthCONx Conference 11.25.2019 Iveric Bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapy 11.14.2019 Iveric Bio to Host a Zimura® R&D Symposium for Investors / Analysts on November 20, 2019 11.12.2019 Iveric Bio Reports Third Quarter 2019 Operational Highlights and Financial Results 11.12.2019 Iveric Bio Initiating Second Pivotal Clinical Trial of Zimura® in GA with 1Q 2020 Targeted for First Patient Enrolled 11.05.2019 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 11.04.2019 Iveric Bio to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 12, 2019 10.29.2019 Iveric Bio Appoints Abraham Scaria, PhD, as Chief Scientific Officer Pagination First page « first Previous page ‹ previous … Page 10 Page 11 Page 12 Page 13 Current page 14 Page 15 Page 16 Page 17 Page 18 … Next page next › Last page last »
